Form 4 for BGMS Bio Green Med Solution, Inc.
Accepted 2023-12-26 00:00:00 ET · period of report 2023-12-21 · accession 0001104659-23-129185 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-26 | 2023-12-21 | BGMS | Rombotis Spiro George | Pres, CEO, Dir | P - Purchase | $3.32 | +6,070 | 68.7K | +10% | +$20.2K |
| D | 2023-12-26 | 2023-12-21 | BGMS | Rombotis Spiro George | Pres, CEO, Dir | P - Purchase | $0.00 | +6,070 | 6,070 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-21 | P | A | 6,070 | $3.32 | 68,658 | D | — | — | (F1) The Reporting Person purchased unregistered shares of the Issuer's common stock in a private placement, pursuant to a Securities Purchase Agreement between the Reporting Person and the Issuer. |
| 2 | Derivative | Warrants (right to buy) | 2023-12-21 | P | A | 6,070 | $0.00 | 6,070 | D | $3.19 · 2023-12-21 to 2030-12-21 | 6,070 Common Stock | (F2) Each share of common stock was purchased with an accompanying warrant at an aggregate purchase price of $3.315 per share and accompanying warrant. |